Wey Jia Fong

Title: Wey Jia Fong: Innovator in Antigen-Binding Proteins

Introduction

Wey Jia Fong is a prominent inventor based in Singapore, known for his significant contributions to the field of biotechnology. He holds a total of 5 patents that focus on innovative antigen-binding proteins and their applications in therapeutic settings.

Latest Patents

Wey Jia Fong's latest patents include groundbreaking work on anti-annexin A2 monoclonal antibodies. This invention relates to an antigen-binding protein that comprises specific heavy and light chain variable domains with defined amino acid sequences. Additionally, he has developed anti-AXL tyrosine kinase receptor antibodies, which are designed to bind to a glycan on the AXL receptor tyrosine kinase. These antibodies can be conjugated to radioisotopes or cytotoxins, allowing for targeted internalization into cells, which has potential applications in cancer detection and treatment.

Career Highlights

Wey Jia Fong is affiliated with the Agency for Science, Technology and Research, where he continues to advance his research in the field of antigen-binding proteins. His work is characterized by a strong focus on therapeutic applications and innovative methodologies.

Collaborations

Wey Jia Fong collaborates with notable colleagues, including Boon Hwa Andre Choo and Simeon Cua, who contribute to his research endeavors and help drive innovation in their field.

Conclusion

Wey Jia Fong's contributions to the field of biotechnology through his patents on antigen-binding proteins highlight his role as a leading inventor. His work not only advances scientific knowledge but also has the potential to impact therapeutic practices significantly.